Nature Communications (Nov 2020)

Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands

  • Ed Slot,
  • Boris M. Hogema,
  • Chantal B. E. M. Reusken,
  • Johan H. Reimerink,
  • Michel Molier,
  • Jan H. M. Karregat,
  • Johan IJlst,
  • Věra M. J. Novotný,
  • René A. W. van Lier,
  • Hans L. Zaaijer

DOI
https://doi.org/10.1038/s41467-020-19481-7
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 7

Abstract

Read online

The Netherlands is a country highly affected by the COVID-19 pandemic. In this study, Slot, Hogema and colleagues report a low SARS-CoV-2 seroprevalence one month into the outbreak and provide insights into virus exposure by region and age group when widespread non-pharmaceutical interventions are in place.